Psychiatry Research: Neuroimaging
Volume 146, Issue 2 , Pages 137-147 , 31 March 2006

A magnetic resonance spectroscopy investigation of obsessive–compulsive disorder and anxiety

  • Stephen P. Whiteside

      Affiliations

    • Department of Psychiatry and Psychology, West 11, Mayo Clinic, 200 First St. SW, Rochester, MN 55905, United States
    • Corresponding Author InformationCorresponding author. Tel.: +1 507 284 5849; fax: +1 507 284 4158.
  • ,
  • John D. Port

      Affiliations

    • Department of Radiology, Mayo Clinic, Rochester, MN, United States
  • ,
  • Brett J. Deacon

      Affiliations

    • Department of Psychology, University of Wyoming, Laramie, WY, United States
  • ,
  • Jonathan S. Abramowitz

      Affiliations

    • Department of Psychiatry and Psychology, West 11, Mayo Clinic, 200 First St. SW, Rochester, MN 55905, United States

Received 18 August 2005 ,Revised 6 December 2005 ,Accepted 14 December 2005.

References 

  1. Bartha R, Stein MB, Williamson PC, Drost DJ, Neufeld RW, Carr TJ, et al. A short echo 1H spectroscopy and volumetric MRI study of the corpus striatum in patients with obsessive–compulsive disorder and comparison subjects. American Journal of Psychiatry. 1998;155:1584–1591
  2. Baxter LR, Schwartz JM, Bergman KS, Szuba MP, Guze BH, Mazziotta JC, et al Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive–compulsive disorder. American Journal of Psychiatry. 1992;49(9):1560–1563
  3. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Archives of General Psychiatry. 1961;4:561–571
  4. Beck AT, Steer RA, Garbin MG. Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clinical Psychology Review. 1988;8:77–100
  5. Cottraux J, Gerard D, Cinotti L, Froment JC, Deiber MP, Le Bars D, et al. A controlled positron emission tomography study of obsessive and neutral auditory stimulation in obsessive–compulsive disorder with checking rituals. Psychiatry Research: Neuroimaging. 1996;60:101–112
  6. Courvoisie H, Hooper SR, Fine C, Kwock L, Castillo M. Neurometabolic functioning and neuropsychological correlates in children with ADHD-H: preliminary findings. Journal of Neuropsychiatry and Clinical Neurosciences. 2004;16:63–69
  7. Davanzo P, Thomas MA, Yue K, Oshiro T, Belin T, Strober M, et al. Decreased anterior cingulate myo-inositol/creatine spectroscopy resonance with lithium treatment in children with bipolar disorder. Neuropsychopharmacology. 2001;24:359–369
  8. Ebert D, Speck O, Konig A, Berger M, Hennig J, Hohagen F. 1H-magnetic resonance spectroscopy in obsessive–compulsive disorder: evidence for neuronal loss in the cingulate gyrus and the right striatum. Psychiatry Research: Neuroimaging. 1997;74:173–176
  9. First, M.B., Spitzer, R.L., Gibbon, M., Williams, J.B., 1996. Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCID-P), version 2. New York State Psychiatric Institute, Biometrics Research, New York.
  10. Fitzgerald KD, Moore GJ, Paulson LA, Stewart CM, Rosenberg DR. Proton spectroscopic imaging of the thalamus in treatment-naive pediatric obsessive–compulsive disorder. (comment) Biological Psychiatry. 2000;47:174–182
  11. Foa EB, Huppert JD, Leiberg S, Langner R, Kichic R, Hajcak G, et al. The Obsessive–Compulsive Inventory: development and validation of a short version. Psychological Assessment. 2002;14:485–496
  12. Frances A, Docherty JP, Kahn DA. Treatment of obsessive–compulsive disorder. Journal of Clinical Psychiatry. 1997;58:5–72
  13. Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR, et al. The Yale-Brown Obsessive Compulsive Scale: II. Validity. Archives of General Psychiatry. 1989;46:1012–1016
  14. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleishmann RL, Hill CL, et al. The Yale-Brown Obsessive Compulsive Scale: I. Development, use, and reliability. Archives of General Psychiatry. 1989;46:1006–1011
  15. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry. 1960;23:56–62
  16. Lucey JV, Costa DC, Blanes T, Busatto GF, Pilowsky LS, Takei N, et al. Regional cerebral blood flow in obsessive–compulsive disordered patients at rest. Differential correlates with obsessive–compulsive and anxious–avoidant dimensions. British Journal of Psychiatry. 1995;167:629–634
  17. Lucey JV, Costa DC, Adshead G, Deahl M, Busatto G, Gacinovic S, et al. Brain blood flow in anxiety disorders. OCD, panic disorder with agoraphobia, and post-traumatic stress disorder on 99mTcHMPAO single photon emission tomography (SPET). British Journal of Psychiatry. 1997;171:346–350
  18. Ohara K, Isoda H, Suzuki Y, Takehara Y, Ochiai M, Takeda H, et al. Proton magnetic resonance spectroscopy of lenticular nuclei in obsessive–compulsive disorder. Psychiatry Research: Neuroimaging. 1999;92:83–91
  19. Pfund Z, Chugani DC, Juhasz C, Muzik O, Chugani HT, Wilds IB, et al. Evidence for coupling between glucose metabolism and glutamate cycling using FDG PET and 1H magnetic resonance spectroscopy in patients with epilepsy. Journal of Cerebral Blood Flow and Metabolism. 2000;20:871–878
  20. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magnetic Resonance in Medicine. 1993;30:672–679
  21. Rauch SL. Neuroimaging research and the neurobiology of obsessive–compulsive disorder: where do we go from here?. (comment) Biological Psychiatry. 2000;47:168–170
  22. Rosenberg DR, Keshavan MS. A.E. Bennett Research Award. Toward a neurodevelopmental model of obsessive–compulsive disorder. Biological Psychiatry. 1998;43:623–640
  23. Rosenberg DR, MacMaster FP, Keshavan MS, Fitzgerald KD, Stewart CM, Moore GJ. Decrease in caudate glutamatergic concentrations in pediatric obsessive–compulsive disorder patients taking paroxetine. Journal of the American Academy of Child and Adolescent Psychiatry. 2000;39:1096–1103
  24. Rosenberg DR, Amponsah A, Sullivan A, MacMillan S, Moore GJ. Increased medial thalamic choline in pediatric obsessive–compulsive disorder as detected by quantitative in vivo spectroscopic imaging. Journal of Child Neurology. 2001;16:636–641
  25. Rosenberg DR, Mirza Y, Russell A, Tang J, Smith JM, Banerjee SP, et al. Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls. Journal of the American Academy of Child and Adolescent Psychiatry. 2004;43:1146–1153
  26. Russell A, Cortese B, Lorch E, Ivey J, Banerjee SP, Moore GJ, et al. Localized functional neurochemical marker abnormalities in dorsolateral prefrontal cortex in pediatric obsessive–compulsive disorder. Journal of Child and Adolescent Psychopharmacology. 2003;13(Suppl 1):S31–S38
  27. Saxena S, Bota RG, Brody AL. Brain–behavior relationships in obsessive–compulsive disorder. Seminars in Clinical Neuropsychiatry. 2001;6:82–101
  28. Smith EA, Russell A, Lorch E, Banerjee SP, Rose M, Ivey J, et al. Increased medial thalamic choline found in pediatric patients with obsessive–compulsive disorder versus major depression or healthy control subjects: a magnetic resonance spectroscopy study. Biological Psychiatry. 2003;54:1399–1405
  29. Spielberger CD, Gorsuch RL, Lushene RE, Vagg PR, Jacobs GA. Revised Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press; 1983;
  30. Steingard RJ, Yurgelun-Todd DA, Hennen J, Moore JC, Moore CM, Vakili K, et al. Increased orbitofrontal cortex levels of choline in depressed adolescents as detected by in vivo proton magnetic resonance spectroscopy. Biological Psychiatry. 2000;48:1053–1061
  31. Taylor S. The assessment of obsessions and compulsions: reliability, validity and sensitivity to treatment effects. Clinical Psychology Review. 1995;15:261–296
  32. Whiteside SP, Port JD, Abramowitz JS. A meta-analysis of functional neuroimaging in obsessive–compulsive disorder. Psychiatry Research: Neuroimaging. 2004;132:69–79

PII: S0925-4927(05)00212-X

doi: 10.1016/j.pscychresns.2005.12.006

Psychiatry Research: Neuroimaging
Volume 146, Issue 2 , Pages 137-147 , 31 March 2006